Evidence map›Paper›PMID 30881623›Full record

ArticleChemical science2019

Katsumasa Fujiki, Yousuke Kanayama, Shinya Yano, Nozomi Sato, Takuya Yokokita, Peni Ahmadi, Yasuyoshi Watanabe, Hiromitsu Haba, Katsunori Tanaka

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Therapeutic efficacy ofChemical science · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 3 countries.

Katsumasa FujikiBiofunctional Synthetic Chemistry Laboratory , RIKEN Cluster for Pioneering Research , 2-1 Hirosawa , Wako , Saitama 351-0198 , Japan . Email: kotzenori@riken.jp.
Yousuke KanayamaLaboratory for Pathophysiological and Health Science , RIKEN Center for Biosystems Dynamics Research , 6-7-3 Minatojima-minamimachi, Chuo-ku , Kobe , Hyogo 650-0047 , Japan.
Shinya YanoNuclear Chemistry Research Team , RIKEN Nishina Center for Accelerator-Based Science , 2-1 Hirosawa , Wako , Saitama 351-0198 , Japan.
Nozomi SatoNuclear Chemistry Research Team , RIKEN Nishina Center for Accelerator-Based Science , 2-1 Hirosawa , Wako , Saitama 351-0198 , Japan.
Takuya YokokitaNuclear Chemistry Research Team , RIKEN Nishina Center for Accelerator-Based Science , 2-1 Hirosawa , Wako , Saitama 351-0198 , Japan.
Peni AhmadiBiofunctional Synthetic Chemistry Laboratory , RIKEN Cluster for Pioneering Research , 2-1 Hirosawa , Wako , Saitama 351-0198 , Japan . Email: kotzenori@riken.jp.
Yasuyoshi WatanabeLaboratory for Pathophysiological and Health Science , RIKEN Center for Biosystems Dynamics Research , 6-7-3 Minatojima-minamimachi, Chuo-ku , Kobe , Hyogo 650-0047 , Japan.
Hiromitsu HabaNuclear Chemistry Research Team , RIKEN Nishina Center for Accelerator-Based Science , 2-1 Hirosawa , Wako , Saitama 351-0198 , Japan.
Katsunori TanakaBiofunctional Synthetic Chemistry Laboratory , RIKEN Cluster for Pioneering Research , 2-1 Hirosawa , Wako , Saitama 351-0198 , Japan . Email: kotzenori@riken.jp.ORCID 0000-0001-6932-4802
Wako University · JPRIKEN Center for Biosystems Dynamics Research · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

α-Emission radiotherapeutics has potential to be one of most effective cancer therapeutics. Herein, we report a facile synthesis of an

Identifiers

PMID30881623
PMCPMC6385556
OpenAlexW2906106047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.